. Normal phase HPLC-APCI-MS-MS analysis of oxysterols free radical oxidation of cholesta-6,8-dienol (A) and cholesta-6,8(14)-dienol (B). Peaks not derived from H-9 or H-14 mechanism were marked on the chromatograms as "*". D was added to each sample as a standard for proper comparison of the retention times between different chromatograms. Peaks not derived from H-9 or H-14 mechanism were marked on the chromatograms as "*". D was added to each sample as a standard for proper comparison of the retention times between different chromatograms. 
S6
Scheme S1. Synthesis of cholesta-6,8(9)-dienol. S1 and S2 were synthesized according to a previously published procedure.
S1
Cholesta-6,8(9)-dienol. Mesyl chloride (100 mg, 0.87 mmol) was added dropwise to a solution of S2 (300 mg, 0.581 mmol) in pyridine (6.5 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 0.5 hr and at room temperature for an additional 45 min. The reaction mixture was then diluted with hexanes (20 mL), washed with water (10 mL) and brine (10 mL), and then dried over MgSO 4 . The crude product was purified by flash column chromatography on silica gel (hexanes:ethyl acetate = 20:1) to give a mixture of 3β-(tert-butyldimethylsilyl)-cholestadienols as shown in Scheme S1 as a white solid. The mixture (128 mg, 0.256 mmol) was then dissolved in THF (3.5 mL), to which was added tetrabutylammonium fluoride (1.0 M in THF, 780 µL). The reaction was stirred at room temperature for 2 hr and was then diluted with ethyl acetate (20 mL), washed with saturated NaHCO 3 (10 mL), water (10 mL), and brine (10 mL), and dried over MgSO 4 . The crude mixture was first purified by flash column chromatography (hexanes:ethyl acetate = 5:1) to give a mixture of 7-DHC, cholesta-6,8(9)-dienol, and cholesta-6,8(14)-dienol (68 mg in total, 30%). Part of the cholestadienol mixture was further purified by reverse phase HPLC-UV (Supelco Discovery C18; 250 × 4.6 mm; 5µm; acetonitrile:methanol = 10:90; 1.0 mL/min; see Figure S7 ) to give cholesta-6,8(9)-dienol as a white amorphous solid (16 mg). The NMR spectra matched those reported previously. 13 C NMR (125 MHz, CDCl 3 ): δ 10. 9, 12.5, 18.9, 22.7, 23.0, 23.3, 23.8, 24.1, 28.2, 29.0, 31.7, 33.7, 35.9, 36.2, 36.3, 36.4, 36.8, 39.7, 42.1, 42.2, 50.3, 54.9, 71.4, 125.8, 128.8, 128.9, 139 UV spectra:
Cholesta-6,8(14)-dienol:
